Security key
89422G107
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)
CUSIP: 89422G107
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 69,779,173
- Total 13F value
- $1,719,469,986
- Share change
- -127,862
- Put/Call ratio
- 29%
- SEC-reported price per share
- $24.64
- Number of holders
- 168
- Value change
- -$2,015,044
- Number of buys
- 82
- Number of sells
- 79
- Shares outstanding
- 92,930,114
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
168
Top holders
10
TVTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Travere Therapeutics, Inc. SEC filings
Travere Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89422G107
Recent filing periods:
Ownership snapshot
Top reported holders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 5.7%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5.7%
RA CAPITAL MANAGEMENT, L.P.
5.3%
BlackRock Finance, Inc.
4.8%
Janus Henderson Group Ltd.
4.3%
MACQUARIE GROUP LTD
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
5.7%
|
$128,904,000
5,320,000 shares
|
— | 30 Jun 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
5.3%
|
$119,283,000
4,922,941 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.8%
|
$109,096,000
4,502,559 shares
|
— | 30 Jun 2022 |
| Janus Henderson Group Ltd. |
13F
Company
|
4.3%
|
$97,871,000
4,038,631 shares
|
— | 30 Jun 2022 |
| MACQUARIE GROUP LTD |
13F
Company
|
3.9%
|
$88,893,000
3,668,679 shares
|
— | 30 Jun 2022 |
| STATE STREET CORP |
13F
Company
|
3.9%
|
$87,402,000
3,607,165 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
168
Shares
69,779,173
Rows available
168
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
166
Q3 2022 holders
168
Holder diff
2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend